Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock

Critical Care Medicine

Volumn 35, Issue 5, 2007, Pages 1277-1283

  Varpula, Marjut ^a   Pulkki, Kari ^a   Karlsson, Sari ^b   Ruokonen, Esko ^c   Pettilä, Ville ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Amino terminal pro brain natriuretic peptide; Intensive care; Mortality; Natriuretic peptides; Sepsis; Septic shock

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CULTURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DATA ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; INFORMED CONSENT; INTENSIVE CARE UNIT; LABORATORY TEST; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; THROMBOCYTE COUNT;

EID: 34247398791     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000261893.72811.0F     Document Type: Article

References (42)

1. Clerico A, Recchia FA, Passino C, et al: Cardiac endocrine function is an essential component of the homeostatic regulation network: Physiological and clinical implications. Am J Physiol Heart Circ Physiol 2006; 290:17-29
2. Ruskoaho H: Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003; 24:341-356
3. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 1998; 339:321-328
4. Nakagawa O, Ogawa Y, Itoh H, et al: Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 1995; 96:1280-1287
5. Doust JA, Glasziou PP, Pietrzak E, et al: A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 2004; 164:1978-1984
6. Mueller T, Gegenhuber A, Poelz W, et al: Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 2005; 91:606-612
7. Mueller T, Gegenhuber A, Poelz W, et al: Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease. Clin Chim Acta 2004; 341:41-48
8. Richards AM, Nicholls MG, Espiner EA, et al: B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003; 107:2786-2792
9. Ray P, Arthaud M, Birolleau S, et al: Comparison of brain natriuretic peptide and probrain natriuretic peptide in the diagnosis of cardiogenic pulmonary edema in patients aged 65 and older. J Am Geriatr Soc 2005; 53:643-648
10. Jason P, Keang LT, Hoe LK: B-type natriuretic peptide: Issues for the intensivist and pulmonologist. Crit Care Med 2005; 33:2094-2113
11. Bionda C, Bergerot C, Ardail D, et al: Plasma BNP and NT-proBNP assays by automated immunoanalyzers: Analytical and clinical study. Ann Clin Lab Sci 2006; 36:299-306
12. Mueller T, Gegenhuber A, Dieplinger B, et al: Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples. Clin Chem Lab Med 2004; 42:942-944
13. Berendes E, Van Aken H, Raufhake C, et al: Differential secretion of atrial and brain natriuretic peptide in critically ill patients. Anesth Analg 2001; 93:676-682
14. Cuthbertson BH, Patel RR, Croal BL, et al: B-type natriuretic peptide and the prediction of outcome in patients admitted to intensive care. Anaesthesia 2005; 60:16-21
15. Jefic D, Lee JW, Jefic D, et al: Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients. Chest 2005; 128:288-295
16. Rudiger A, Gasser S, Fischler M, et al: Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 2006; 34:2140-2144
17. Brueckmann M, Huhle G, Lang S, et al: Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005; 26:527-534
18. Roch A, Allardet-Servent J, Michelet P, et al: NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 2005; 33:1001-1007
19. Charpentier J, Luyt CE, Fulla Y, et al: Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004; 32:660-665
20. Castillo JR, Zagler A, Carrillo-Jimenez R, et al: Brain natriuretic peptide: A potential marker for mortality in septic shock. Int J Infect Dis 2004; 8:271-274
21. Hoffmann U, Brueckmann M, Bertsch T, et al: Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Clin Lab 2005; 51:373-379
22. 21a.Karlsson S, Varpula M, Ruokonen E, et al: Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: The Finnsepsis study. Intensive Care Med 2007;33:435-443
23. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41
24. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
25. Le Gall JR, Lemeshow S, Saulnier F: A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
26. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22:707-710
27. Witthaut R, Busch C, Fraunberger P, et al: Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: Impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 2003; 29:1696-1702
28. Kazanegra R, Cheng V, Garcia A, et al: A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study. J Card Fail 2001; 7:21-29
29. Iwanaga Y, Nishi I, Furuichi S, et al: B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: Comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006; 21:742-748
30. Forfia PR, Watkins SP, Rame JE, et al: Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 2005; 17:1667-1671
31. Mclean AS, Poh G, Huang SJ: The effects of acute fluid loading on plasma B-type natriuretic peptide levels in a septic shock patient. Anaesth Intensive Care 2005; 33:528-530
32. Maeder M, Ammann P, Kiowski W, et al: B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction. Eur J Heart Fail 2005; 7:1164-1167
33. Harada E, Nakagawa O, Yoshimura M, et al: Effect of interleukin-1 beta on cardiac hypertrophy and production of natriuretic peptides in rat cardiocyte culture. J Mol Cell Cardiol 1999; 31:1997-2006
34. Tanaka T, Kanda T, Takahashi T, et al: Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J Int Med Res 2004; 32:57-61
35. Tomaru Ki K, Arai M, Yokoyama T, et al: Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes. J Mol Cell Cardiol 2002; 34:649-659
36. Court O, Kumar A, Parrillo JE, et al: Clinical review: Myocardial depression in sepsis and septic shock. Crit Care 2002; 6:500-508
37. Ma KK, Banas K, de Bold AJ: Determinants of inducible brain natriuretic peptide promoter activity. Regul Pept 2005; 128:169-176
38. Hanford DS, Thuerauf DJ, Murray SF, et al: Brain natriuretic peptide is induced by alpha 1-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes. J Biol Chem 1994; 269:227-233
39. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 23:588-595
40. Vatta MS, Presas MF, Bianciotti LG, et al: B and C types natriuretic peptides modify norepinephrine uptake and release in the rat adrenal medulla. Peptides 1997; 18:1483-1489
41. Hopkins WE, Chen Z, Fukagawa NK, et al: Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: Enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 2004; 109:2872-2877
42. Yoshizumi M, Tsuji H, Nishimura H, et al: Natriuretic peptides regulate the expression of tissue factor and PAI-1 in endothelial cells. Thromb Haemost 1999; 82:1497-1503